SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation-Reference-Cited by-同舟云学术

SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Published:2003-04-07 Issue:1 Volume:306 Page:407-420
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Cohen C.,Bergis O. E.,Galli F.,Lochead A. W.,Jegham S.,Biton B.,Léonardon J.,Avenet P.,Sgard F.,Besnard F.,Graham D.,Coste A.,Oblin A.,Curet O.,Voltz C.,Gardes A.,Caille D.,Perrault G.,George P.,Soubrié P.,Scatton B.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain

2. Effects of D 1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity

3. SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018;Pharmacology Research & Perspectives;2022-01-18

2. Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands;ELIFE;2022

3. Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands;eLife;2022-01-04

4. Neurobiological Mechanisms of Nicotine Reward and Aversion;Pharmacological Reviews;2022-01

5. Nanoscale Sub-Compartmentalization of the Dendritic Spine Compartment;Biomolecules;2021-11-15